CD6 is a target for cancer immunotherapy is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 32AR007080
Internal funding - University of Michigan
Grant: N/A
NEI NIH HHS
Grant: R01 EY025373
NCI NIH HHS
Grant: R41 CA275639
NIAMS NIH HHS
Grant: T32 AR007080
NIAID NIH HHS
Grant: UM1 AI144298
National Institutes of Health
Grant: 3T32AR007080-45S1
Scientist Training in Rheumatology Research
FWCI
2.64
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers
Additional file 2 of SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers
Additional file 3 of SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers
Additional file 3 of SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers
Additional file 1 of SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers
Additional file 1 of SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers